Browse by Poster Presenter

Skip to main content

ICPE 2021 Main banner

Browse by Poster Presenter

Type here to filter the list

All
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

E
Earla, Jagadeswara Rao

Merck & Co., Inc.
(P-293) Factors Associated with Different Dosage Forms of Disease-modifying Agents in Older Adults with Multiple Sclerosis
Jagadeswara Rao Earla
Favorite
Eaton, Susan

Biogen
(P-154) Real-world Adherence of Nusinersen for the Treatment of Spinal Muscular Atrophy (SMA) Using US Electronic Health Records
Susan Eaton
Favorite
Edwards, Jessie

University of North Carolina at Chapel Hill
(P-576) Modeling Drug Treatment Effects on Breast Cancer in the Setting of Differential Screening
Jessie Edwards
Favorite
Egberts, Toine C.G.

Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Faculty of Science, Utrecht University, Utrecht, the Netherlands
(P-360) Monitoring of Adverse Drug Reaction-related Parameters in Children, Youth and Young Adults Prescribed Antipsychotic Drugs by General Practitioners
Toine C.G. Egberts
Favorite
Eggenschwiler, Laura

Department of Ophthalmology, University Hospital Basel, Basel, Switzerland
(P-003) Incidence Rates (IR) and IR Ratios of Alzheimer’s Disease in Patients with Cataract Compared to the General Population: Analyses Using the Clinical Practice Research Datalink (CPRD)
Laura Eggenschwiler
Favorite
Eggo, Rosalind

London School of Hygiene and Tropical Medicine
(P-586) Association Between the Use of Oral Anticoagulant and Risk of Adverse COVID-19 Outcomes: An Opensafely Analysis
Rosalind Eggo
Favorite
Ehrenstein, Vera

Department Of Clinical Epidemiology, Aarhus University, Aarhus, Denmark
(P-071) Inception to Conception: A Conceptual Framework for Characterizing Pharmacoepidemiologic Data Sources. a Study from the Conception Project
Vera Ehrenstein
Favorite
(P-567) SIGMA Consortium: A New Era of Collaboration to Study the Safety and Effectiveness of Medical Interventions
Vera Ehrenstein
Favorite
Eiffert, Samantha

UNC Eshelman School of Pharmacy
(P-094) Intravenous Vancomycin Use at Discharge and 90-day Risk of Readmission or Death
Samantha Eiffert
Favorite
Eisinger, Johannes

Patient Safety Oncology, Novartis, Basel, Switzerland
(P-070) Risk of Thrombotic Microangiopathy with Tyrosine Kinase Inhibitors: A Disproportionality Analysis from Vigibase and AERS Databases
Johannes Eisinger
Favorite
Ejlertsen, Bent

Danish Breast Cancer Group, Copenhagen, Denmark
(P-334) Socioeconomic Status and Prognosis in Premenopausal Breast Cancer: A Population-based Cohort Study in Denmark
Bent Ejlertsen
Favorite
Ekuma, Okechukwu

University of Manitoba
(P-208) The Disease-modifying Drugs for Multiple Sclerosis and Subsequent Health Service Use: A Population-based Study
Okechukwu Ekuma
Favorite
El‐Dahiyat, Faris

College of Pharmacy, Al Ain University
(P-134) Cost Considerations of Dermatological Care in Jordan: A Cross-sectional Study
Faris El‐Dahiyat
Favorite
Eldridge, Elizabeth

Health Catalyst
(P-449) Characterizing “long-covid” Using Real World Data: Post-discharge Clinical Course Among Patients Initially Hospitalized for COVID-19
Elizabeth Eldridge
Favorite
Elhussein, Leena

Musculoskeletal Pharmaco- and Device Epidemiology Group Centre for Statistics in Medicine (CSM) | Nu
(P-427) Use of and Adherence to Bisphosphonates in Elderly Patients with Complex Health Needs: An Analysis of UK Primary Care Records
Leena Elhussein
Favorite
Elliott, Taylor

University of Kentucky College of Pharmacy
(P-246) An Evaluation of Injurious Falls and Fall-risk-increasing-drug (FRID) Prescribing Behaviors in a Nationally Representative Sample & the Pharmacist’s Role in Fall Prevention
Taylor Elliott
Favorite
El-Mourad, Jihane

Université Laval
(P-466) Risk of Emergency Department Visits or Hospitalization for Cardiovascular Events in Patients with Medical Cannabis Authorization
Jihane El-Mourad
Favorite
(P-597) Medical Cannabis Authorization and Drugs and Other Substances Use Disorders: longitudinal Cohort Study
Jihane El-Mourad
Favorite
Elseviers, Monique

Ghent University
(P-476) Efficacy of the Optimeds Tool for Multidisciplinary Medication Review in Belgian Nursing Homes
Monique Elseviers
Favorite
(P-477) Feasibility and Acceptability of the Optimeds Tool for Multidisciplinary Medication Review in Belgian Nursing Homes
Monique Elseviers
Favorite
Elson, William

London School of Hygiene and Tropical Medicine
(P-586) Association Between the Use of Oral Anticoagulant and Risk of Adverse COVID-19 Outcomes: An Opensafely Analysis
William Elson
Favorite
Eltonsy, Sherif

University of Manitoba
(P-165) Trends of Anti-epileptic Drugs Use During Pregnancy in Manitoba, Canada: A 20-year Utilization Study
Sherif Eltonsy
Favorite
Elwood, Mark

University of Auckland
(P-204) Use of Beta Blockers and Death from Breast Cancer in New Zealand Breast Cancer Patients
Mark Elwood
Favorite
Enger, Cheryl

Optum, Boston, MA, USA
(P-206) Pediatric Fentanyl Overdose Within an Electronic Health Record Database
Cheryl Enger
Favorite
Eom, Joohyeon

Chung-Ang University
(P-366) Trajectories of Corticosteroid Dosing Pattern Among Patients with Systemic Lupus Erythematosus
Joohyeon Eom
Favorite
(P-367) The Patterns of Spontaneous Reports of Neurologic, Hematologic, and Immunologic Adverse Events Following Immunization in Korea
Joohyeon Eom
Favorite
Ernst, Martin

University of Southern Denmark
(P-564) Melatonin Use Among Children, Adolescents, and Young Adults. a Danish Nationwide Drug Utilization Study
Martin Ernst
Favorite
Eron, Joseph

University of North Carolina-Chapel Hill
(P-037) Vaporized Nicotine (E-cig) Use Among People with HIV in Care in the US
Joseph Eron
Favorite
Esposito, Daina

Boston University School of Public Health
(P-543) The Incidence Rates of Hepatobiliary Diseases Among Non-alcoholic Steatohepatitis Patients Stratified by fibrosis-4 (FIB-4) Index for Liver Fibrosis
Daina Esposito
Favorite
Estevez, Irisdaly

Aetion, Inc.
(P-514) Impact of Increasing Enrollment Requirements in Administrative Claims Data
Irisdaly Estevez
Favorite
Eurich, Dean

School of Public Health, University of Alberta
(P-466) Risk of Emergency Department Visits or Hospitalization for Cardiovascular Events in Patients with Medical Cannabis Authorization
Dean Eurich
Favorite
(P-597) Medical Cannabis Authorization and Drugs and Other Substances Use Disorders: longitudinal Cohort Study
Dean Eurich
Favorite
Evans, Alison

DSRU
(P-145) Real World Utilization of 91-day Extended Levonorgestrel-containing Combined Oral Contraceptives in Europe: A Multinational Database Study
Alison Evans
Favorite
Evans, Charity

University of Saskatchewan
(P-208) The Disease-modifying Drugs for Multiple Sclerosis and Subsequent Health Service Use: A Population-based Study
Charity Evans
Favorite
Evans, David

University of Oxford
(P-586) Association Between the Use of Oral Anticoagulant and Risk of Adverse COVID-19 Outcomes: An Opensafely Analysis
David Evans
Favorite
Evans, Stephen JW

London School of Hygiene & Tropical Medicine
(P-586) Association Between the Use of Oral Anticoagulant and Risk of Adverse COVID-19 Outcomes: An Opensafely Analysis
Stephen JW Evans
Favorite
Ewig, Celeste

Chinese University of Hong Kong
(P-254) Chronic Prescription Medications and Prevalence of Polypharmacy in Survivors of Childhood Cancer
Celeste Ewig
Favorite
Ewing, Altovise

Genentech, Inc.
(P-056) Genetic Heterogeneity Patterns of Electronic Medical Record (EMR)-Derived Race Groups in a Deidentified Clinico-genomic Database (CGDB)
Altovise Ewing
Favorite
Eworuke, Efe

Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, U.S. Food and Drug Administration
(P-240) Analysis of COVID-19 Patient Experiences Reported Through Social Media
Efe Eworuke
Favorite
(P-393) Pregnancy in Women with Heart Failure: A Cross-sectional Study in the Sentinel System
Efe Eworuke
Favorite
(P-629) How Under-coded Is Pediatric Hypertension?: Comparison of Claims and Electronic Health Record (EHR) Data
Efe Eworuke
Favorite